MCF7 and MDA-MB-231 exhibited increased METTL3 expression compared to MCF10-A (Fig. 2A), which was also observed in the broader panel of breast cancer cell lines with the exception of the Tamoxifen resistant cell line T47D1 (Supplementary Fig. 2B). The gene discussed is METTL3; the disease is breast carcinoma.